The global Immunohistochemistry Market is estimated to be valued at US$1,463.6 million in 2022 and is expected to exhibit a CAGR of 6.6% over the forecast period 2022-2030, according to a new report published by Coherent Market Insights.
Market Overview:
Immunohistochemistry (IHC) is a widely-used technique in the field of pathology
and histology that uses specific antibodies to detect specific antigens in
tissue samples. This technique provides important information about the
presence and distribution of proteins, making it an essential tool in medical
research and diagnostics. IHC plays a crucial role in diagnosing various
diseases, aiding in tumor classification, determining treatment plans, and
monitoring patient response to therapy. The global immunohistochemistry market
is driven by the rising prevalence of chronic diseases, increasing demand for
personalized medicine, advancements in cancer research, and growing applications
of IHC in drug development.
Market Key Trends:
One of the key trends observed in the immunohistochemistry market is the
growing adoption of multiplex immunohistochemistry. Multiplex IHC allows for
the simultaneous detection of multiple antigens within a single tissue sample,
providing more comprehensive information compared to conventional IHC
techniques. This technique enables researchers and pathologists to study the
spatial distribution of different proteins and understand their interplay within
the tissue microenvironment. Multiplex IHC is particularly useful in cancer
research, where it aids in the identification of biomarkers and the
characterization of tumor heterogeneity. Furthermore, the development of
automated staining systems and advanced imaging technologies has improved the
efficiency and accuracy of multiplex IHC, further driving its adoption in
research and diagnostic laboratories.
Segment Analysis:
The immunohistochemistry market can be segmented based on product, application,
end user, and region. In terms of product, the antibodies segment dominates the
market due to their high demand for disease diagnosis and research
applications. Antibodies are widely used in immunohistochemistry for
identifying specific antigens in tissues and cells. The increasing prevalence
of chronic diseases and the growing need for personalized medicine are driving
the demand for antibodies in immunohistochemistry.
Based on application, the cancer diagnosis segment holds a significant share in
the market. Immunohistochemistry plays a crucial role in cancer diagnosis by
identifying specific biomarkers and proteins that can help determine the type,
stage, and prognosis of cancer. The rising incidence of cancer globally and the
increasing demand for accurate and precise cancer diagnosis are contributing to
the dominance of this segment.
In terms of end user, the diagnostic laboratories segment dominates the market.
Immunohistochemistry tests are primarily performed in diagnostic laboratories
for disease diagnosis and research purposes. The high demand for
immunohistochemistry tests in diagnostic laboratories, coupled with the
increasing number of diagnostic laboratories worldwide, is fueling the growth
of this segment.
Key Takeaways:
The global Immunohistochemistry
Market Share is expected to
witness high growth, exhibiting a CAGR of 6.6% over the forecast period of
2022-2030. The market is driven by various factors, including the increasing
prevalence of chronic diseases, the growing demand for personalized medicine,
and the rising incidence of cancer.
Regionally, North America is the fastest-growing and dominating region in the
immunohistochemistry market. The presence of well-established healthcare
infrastructure, advanced research facilities, and a high focus on R&D
activities in North America are contributing to the growth of the market in
this region. Additionally, the increasing adoption of immunohistochemistry in
cancer diagnosis and the presence of key market players in North America
further propel market growth.
Key players operating in the immunohistochemistry market include Merck KGaA,
Rockland Immunochemicals, Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher
Scientific, PerkinElmer, Inc., Bio-Rad Laboratories, Inc., Cell Signaling
Technology, Inc., Bio SB, Agilent Technologies, Inc., Abcam plc., Becton,
Dickinson and Company, Miltenyi Biotec, Biocare Medical, LLC, Eagle
Biosciences, Inc., Bio-Techne, Diagnostic Biosystems, Inc., and BioGenex. These
key players dominate the market through their extensive product portfolios,
strategic collaborations, and strong distribution networks. They are focused on
developing innovative solutions to meet the growing demand for
immunohistochemistry tests and enhance their market presence.
Read More,
0 Comments